Zoran Čulig

Research interests

Publications

• ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance

  Frontiers in Molecular Biosciences · 2020 · 10.3389/fmolb.2020.00036

• Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review

  Gerontology · 2019 · 10.1159/000496289

• Alternative mechanisms of miR-34a regulation in cancer

  Cell Death and Disease · 2017 · 10.1038/cddis.2017.495

• The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy

  Clinical Cancer Research · 2017 · 10.1158/1078-0432.ccr-17-0989

• JAK-STAT signaling in cancer: From cytokines to non-coding genome

  Cytokine · 2016 · https://doi.org/10.1016/j.cyto.2016.06.017

• Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer

  Oncotarget · 2016 · 10.18632/oncotarget.9537

• STAT3 regulated ARF expression suppresses prostate cancer metastasis

  Nature Communications · 2015 · 10.1038/ncomms8736

• ZEB1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

  EMBO Molecular Medicine · 2015 · 10.15252/emmm.201404396

• Androgen receptor signaling in prostate cancer

  Cancer and Metastasis Reviews · 2014 · 10.1007/s10555-013-9474-0

• Prevention and early detection of prostate cancer

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70211-6

• The Mutational Landscape of Prostate Cancer

  European Urology · 2013 · 10.1016/j.eururo.2013.05.029

• Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

  American Journal Of Pathology · 2012 · 10.1016/j.ajpath.2012.08.011

• Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines

  Molecular Cancer Therapeutics · 2011 · 10.1158/1535-7163.mct-11-0182

• Interleukin-6: A multifunctional targetable cytokine in human prostate cancer

  Molecular and Cellular Endocrinology · 2011 · 10.1016/j.mce.2011.05.033

• Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth

  Molecular Therapy · 2009 · 10.1038/mt.2009.237

• Interleukin‐6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival

  International Journal of Cancer · 2007 · 10.1002/ijc.23261

• Interleukin-6 regulation of prostate cancer cell growth

  Journal of Cellular Biochemistry · 2005 · 10.1002/jcb.20477

• Androgen receptors in prostate cancer.

  Endocrine Related Cancer · 2002 · 10.1677/erc.0.0090155

• Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

  The Journal of Pathology · 2000 · 10.1002/1096-9896(2000)9999:9999<::aid-path633>3.0.co;2-x

• Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

  British Journal of Cancer · 1999 · https://doi.org/10.1038/sj.bjc.6690684

• Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

  PubMed · 1998

• Regulation of prostatic growth and function by peptide growth factors

  The Prostate · 1996 · https://doi.org/10.1002/(sici)1097-0045(199606)28:6<392::aid-pros9>3.0.co;2-c

• Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

  PubMed · 1994

• Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

  Molecular Endocrinology · 1993 · https://doi.org/10.1210/mend.7.12.8145761

• Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

  Molecular Endocrinology · 1993 · 10.1210/me.7.12.1541

Current projects

No projects listed.